Clinical Trial Update: Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial update showing efficacy, safety and tolerability of KLU156 in adults and children with uncomplicated Plasmodium falciparum malaria. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• KLU156

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Uncomplicated Plasmodium Falciparum Malaria | Phase 3 | Status: COMPLETED